COMMUNIQUÉS West-GlobeNewswire

Assertio Therapeutics to Present at the 16th Annual Morgan Stanley Global Healthcare Conference
05/09/2018
LAKE FOREST, Ill., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, today announced that members of senior [...]
AIT Therapeutics Announces $526,500 Sale of Common Stock To Institutional Investor, Lincoln Park Capital Fund
05/09/2018
GARDEN CITY, N.Y. and REHOVOT, Israel, Sept. 05, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB:AITB) (“AIT Therapeutics or the “Company”), a clinical-stage medical device and biopharmaceutical company focused [...]
Progressive Care Inc. CEO to Speak at First US FlyPharma Conference in Miami, Fla.
05/09/2018
MIAMI, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that the company will be attending and speaking at the [...]
Yield10 Bioscience Reports Promising Seed Yield Results for Novel Yield Trait C3004 in Growth Chamber Studies in Camelina
05/09/2018
--Fast-Tracking Deployment of C3004 Trait into Canola and Soybean WOBURN, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change [...]
Inovio Doses 1st Subject in Phase 1/2 Clinical Trial For Vaccine Against Deadly MERS Infection
05/09/2018
PLYMOUTH MEETING, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today announced the dosing of the first subject with its vaccine to prevent infection from the deadly MERS [...]
Tetra Bio-Pharma Secures CBD Supply Agreement for Genacol Partnership
05/09/2018
ORLEANS, Ontario, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that it has secured a [...]
WishBone Medical, Inc. announces new AlloMate Bone Pin System
05/09/2018
WARSAW, Ind., Sept. 05, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. announces the official launch of the single-use, sterile packed AlloMate Bone Pin System for the maintenance of alignment and fixation of bone [...]
Fibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma
05/09/2018
EXTON, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
DiaMedica Therapeutics Announces the Appointment of Dr. Harry Alcorn Jr. as Chief Medical Officer
05/09/2018
MINNEAPOLIS, Sept. 05, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ” and “ DiaMedica ”) (TSX-V:DMA) (OTCQB:DMCAF) announces the recent appointment of Harry Alcorn Jr. Pharm.D. as Chief Medical [...]
Palvella Therapeutics Appoints Rare Disease Senior Executive Elaine J. Heron, PhD to Board of Directors
05/09/2018
Dr. Heron Adds Deep Expertise in Orphan Drug Development and Commercialization Wayne, PA, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a rare disease biopharmaceutical company focused on developing [...]
PhaseBio Secures $34 Million in Series D Financing
05/09/2018
Proceeds will advance clinical development of PB2452, a potentially first-in-class reversal agent for patients on ticagrelor, and PB1046, a novel treatment for PAH MALVERN, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) -- [...]
Biotricity Developing ECG Patch for Anticipated Q1 2019 Release
05/09/2018
Biopatch to Extend Comprehensive Bioflux Solution with Advanced Diagnostics and High Usability REDWOOD CITY, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY ), a medical diagnostic and consumer [...]
Tyme Exceeds Enrollment Expectations for the Phase II Trial of SM-88 in Pancreatic Cancer
05/09/2018
NEW YORK, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), today announced that the number of currently consented or randomized subjects has exceeded the enrollment target for the Stage 1 dose [...]
PetVivo Holdings, Inc. Welcomes Mr. Michael Haider as Senior Project Manager and Mr. Joel Hapke as Manager of Mfg., Analytical and Process Engineering
05/09/2018
(All Press Releases Will Be Available for Viewing on Facebook or the Web at www.petvivo.com ) MINNEAPOLIS, Sept. 05, 2018 (GLOBE NEWSWIRE) -- OTCPINK: PETV PetVivo Holdings, Inc. ( www.petvivo.com ) an emerging [...]
Arch Therapeutics Reports Topline Results from Skin Sensitization Study of AC5
05/09/2018
Study finds no evidence of irritation or allergic reaction in any enrolled subject FRAMINGHAM, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of [...]
FDA Confirms Target Decision Date for Novel Single-Vial Formulation of EGRIFTA® (Tesamorelin for Injection)
05/09/2018
MONTREAL, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies”) (TSX: TH) today announced that the Food and Drug Administration (“FDA”) has set the target date to November 3, 2018 to issue a [...]
La FDA confirme la date-cible pour une décision sur la nouvelle formulation en fiole unique d’EGRIFTA(MD) (tésamoréline pour injection)
05/09/2018
MONTRÉAL, 05 sept. 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX: TH) a annoncé aujourd’hui que la Food and Drug Administration (« FDA ») a établi au 3 novembre 2018 la date-cible pour une [...]
KemPharm to Present at Two Healthcare Investor Conferences During September 2018
05/09/2018
CORALVILLE, Iowa, Sept. 05, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that its President [...]
Dermira Provides Launch Readiness Update for QBREXZA™ (glycopyrronium) Cloth for Primary Axillary Hyperhidrosis
05/09/2018
Early commercial payer coverage for the therapy includes Express Scripts, Inc. and OptumRx Company announces DermiraConnect, a new patient access program that will provide patients broad access to QBREXZA Therapy is [...]

Pages